B. Riley Wealth Advisors Inc. Sells 3,051 Shares of Sanofi (NASDAQ:SNY)

B. Riley Wealth Advisors Inc. decreased its position in shares of Sanofi (NASDAQ:SNY) by 18.2% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 13,671 shares of the company’s stock after selling 3,051 shares during the quarter. B. Riley Wealth Advisors Inc.’s holdings in Sanofi were worth $776,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also recently made changes to their positions in the company. Northwest Investment Counselors LLC purchased a new stake in shares of Sanofi during the 3rd quarter valued at $29,000. POM Investment Strategies LLC purchased a new position in Sanofi in the second quarter worth $25,000. Concord Wealth Partners lifted its position in Sanofi by 157.8% in the 3rd quarter. Concord Wealth Partners now owns 593 shares of the company’s stock worth $34,000 after buying an additional 363 shares during the last quarter. Arrow Financial Corp purchased a new stake in shares of Sanofi in the 2nd quarter valued at $35,000. Finally, Sunbelt Securities Inc. increased its holdings in shares of Sanofi by 72.1% in the third quarter. Sunbelt Securities Inc. now owns 747 shares of the company’s stock worth $43,000 after buying an additional 313 shares during the period. 14.04% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on the stock. Citigroup raised shares of Sanofi to a “strong-buy” rating in a research report on Tuesday, September 17th. StockNews.com cut Sanofi from a “buy” rating to a “hold” rating in a research report on Thursday, December 12th. Two research analysts have rated the stock with a hold rating, one has assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, Sanofi has a consensus rating of “Moderate Buy” and an average price target of $57.50.

Sanofi Price Performance

Sanofi stock opened at $48.94 on Wednesday. The company has a current ratio of 1.00, a quick ratio of 0.65 and a debt-to-equity ratio of 0.17. The firm has a market capitalization of $124.20 billion, a PE ratio of 24.97, a price-to-earnings-growth ratio of 1.23 and a beta of 0.58. Sanofi has a 12-month low of $45.22 and a 12-month high of $58.97. The firm has a 50-day moving average price of $50.72 and a 200-day moving average price of $52.09.

Sanofi (NASDAQ:SNY) last posted its earnings results on Friday, October 25th. The company reported $1.57 EPS for the quarter, beating analysts’ consensus estimates of $0.22 by $1.35. Sanofi had a net margin of 9.96% and a return on equity of 27.45%. The business had revenue of $13.44 billion for the quarter, compared to the consensus estimate of $16.59 billion. During the same quarter last year, the firm posted $2.55 EPS. The company’s revenue for the quarter was up 12.3% on a year-over-year basis. As a group, equities research analysts forecast that Sanofi will post 4.06 EPS for the current year.

Sanofi Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.